Publications & Works

ATLAS Publication Analytics
Articles 41
All (41)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (37)
ESCI (22)
Scopus (31)
TRDizin (23)
Other Publications (2)

1. Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study.

Azoulay E., McEvoy C., Castro P., Hssain A. A., Taccone F. S., Myatra S. N., et al.
The Lancet. Respiratory medicine , 2026 (SCI-Expanded, Scopus)

2. Clinical pharmacist-led prevention of intravenous drug incompatibilities in an adult ICU: a prospective observational study.

Kayra T., Ferliçolak L., Ateş İ., Altıntaş N. D., Onay-Besikci A.
BMC pharmacology & toxicology , 2026 (SCI-Expanded, Scopus)

3. Ventilator-associated pneumonia in an intensive care unit:A comperative analysis of clinical and microbiological characteristics of COVID-19 and non-COVID-19 patients

SARICAOĞLU E. M., FERLİÇOLAK L., GÜLTEN E., ÇINAR G., AKDEMİR İ., İNAN HEKİMOĞLU M., et al.
TUBERKULOZ VE TORAKS , vol.74, no.1, pp.21-31, 2026 (ESCI, Scopus, TRDizin)

4. The Prognostic Role of Non-Thyroidal Illness Syndrome in Critically Ill Patients: A Retrospective Cohort Study

Ferliçolak L., Aydın R. F., Altıntaş N. D.
Journal of Critical and Intensive Care , vol.16, no.2, pp.57-63, 2025 (ESCI, Scopus, TRDizin)

5. Shortening antibiotic therapy duration for hospital-acquired bloodstream infections in critically ill patients: a causal inference model from the international EUROBACT-2 database.

Gajdos L., Buetti N., Tabah A., Ruckly S., Akova M., Sjöval F., et al.
Intensive care medicine , vol.51, no.3, pp.518-528, 2025 (SCI-Expanded, Scopus)

6. Hypophosphatemia: Unraveling a Lethal Connection with ICU Mortality in Critically Ill COVID-19 Patients: A Multicenter Observational Study

Temel S., Hancı P., Akbudak İ. H., Halaçlı B., Güven G., Bilir Y., et al.
JOURNAL OF MEDICAL BIOCHEMISTRY , vol.43, pp.1-9, 2025 (SCI-Expanded, Scopus)

7. Presentation, management, and outcomes of older compared to younger adults with hospital-acquired bloodstream infections in the intensive care unit: a multicenter cohort study.

Margalit I., Yahav D., Hoffman T., Tabah A., Ruckly S., Barbier F., et al.
Infection , vol.52, no.6, pp.2435-2443, 2024 (SCI-Expanded, Scopus)

8. Effect of adequacy of empirical antibiotic therapy for hospital-acquired bloodstream infections on intensive care unit patient prognosis: a causal inference approach using data from the Eurobact2 study

Loiodice A., Bailly S., Ruckly S., Buetti N., Barbier F., Staiquly Q., et al.
Clinical Microbiology and Infection , vol.30, no.12, pp.1559-1568, 2024 (SCI-Expanded, Scopus)

9. Evaluation of Long-Coronavirus Disease 2019 Cases Readmitted to Intensive Care Units Due to Acute Respiratory Failure: Point Prevalence Study

Tuncay E., Mocin O., Ediboglu O., Adiguzel N., Gungor S., Iscanli I., et al.
THORACIC RESEARCH AND PRACTICE , no.4, pp.162-167, 2024 (ESCI, TRDizin)

10. The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections

Buetti N., Tabah A., Setti N., Ruckly S., Barbier F., Akova M., et al.
Intensive Care Medicine , vol.50, no.6, pp.873-889, 2024 (SCI-Expanded, Scopus)

11. Refeeding Hypophosphatemia in Oldest Old Critically Ill Patients

FERLİÇOLAK L., ALTINTAŞ N. D.
IRISH JOURNAL OF MEDICAL SCIENCE , vol.193, no.2, pp.1085-1089, 2024 (SCI-Expanded, Scopus)

12. A retrospective analysis of carbapenem-resistant Acinetobacter baumannii infections in critically ill patients: Experience at a tertiary-care teaching hospital ICU.

Ferliçolak L., Altıntaş N. D., Yörük F.
Journal of intensive medicine , vol.4, no.2, pp.181-186, 2024 (ESCI, Scopus)

13. Nutritional practices in medical intensive care units: Multicenter, one-day point prevalence study* Pratiques nutritionnelles dans les unités de soins intensifs médicaux : étude de prévalence ponctuelle multicentrique sur une journée

FERLİÇOLAK L., ALTINTAŞ N. D., HALAÇLI B., TEMEL Ş., ÇAKIN Ö., TÜRKOĞLU M., et al.
NUTRITION CLINIQUE ET METABOLISME , vol.37, no.4, pp.221-226, 2023 (SCI-Expanded, Scopus)

14. Does Euthyroid Sick Syndrome Have an Effect on the Outcome of Critically Ill Coronavirus Disease 2019 Patients?

FERLİÇOLAK L., GÖKÇAY CANPOLAT A., NURLU O., ALTINTAŞ N. D.
ENDOCRINOLOGY RESEARCH AND PRACTICE , vol.27, no.4, pp.186-190, 2023 (ESCI, Scopus, TRDizin)

15. Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study

Aslan A. T., Tabah A., Koylu B., Kalem A. K., AKSOY F., Erol C., et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol.78, no.7, pp.1757-1768, 2023 (SCI-Expanded, Scopus)

16. EFFECTS OF DIABETES AND FIRST-WEEK HYPERGLYCEMIC EPISODE FREQUENCY ON THE MORTALITY AND INFLAMMATION IN CRITICALLY ILL COVID-19 PATIENTS: A CASE-CONTROL STUDY

FERLİÇOLAK L., YILDIZ B., ALTINTAŞ N. D.
ACTA ENDOCRINOLOGICA-BUCHAREST , vol.19, no.1, pp.49-53, 2023 (SCI-Expanded, Scopus)

17. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Tabah A., Buetti N., Staiquly Q., Ruckly S., Akova M., Aslan A. T., et al.
Intensive Care Medicine , vol.49, no.2, pp.178-190, 2023 (SCI-Expanded, Scopus) Creative Commons License

18. Ventilator associated pneumonia in COVID-19 patients: A retrospective cohort study

FERLİÇOLAK L., SARICAOĞLU E. M., BİLBAY B., ALTINTAŞ N. D., YÖRÜK F.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.71, no.1, pp.41-47, 2023 (ESCI, Scopus, TRDizin)

19. The Relation of Hepcidin, Vitamin D and Inflammatory Parameters, and Effects on Intensive Care Unit Outcome in Critically Ill COVID-19 Patients

Ferliçolak L., Bildiren N. S., Doğan Ö., Yüksel M., Kurt Yüksel M., Altıntaş N. D.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.75, 2022 (TRDizin)

20. Retrospective Evaluation of Risk Factors for Invasive Candida Infections in a Medical Intensive Care Unit

Bilgin M. K., Ferliçolak L., Evren E., Altıntaş N. D.
Infectious Disease and Clinical Microbiology , vol.4, no.1, pp.62-71, 2022 (ESCI)

21. Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients

Talan L., Kalkan İ., Altintas N. D., Yoruk F.
BALKAN MEDICAL JOURNAL , vol.39, no.4, pp.301-302, 2022 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

22. Acute Kidney Injury Incidence, Risk Factors and Effects on Mortality in Critically ill COVID-19 Patients: A Retrospective Cohort Study

FERLİÇOLAK L., ALKAN TEKEŞ İ., ALTINTAŞ N. D.
Journal of Critical and Intensive Care , vol.13, pp.110-114, 2022 (ESCI, Scopus, TRDizin)

23. Rifampicin combination therapies for colistin-resistant acinetobacter spp. In an intensive care unit Yoğun bakım ünitesinde kolistin dirençli acinetobacter spp. için rifampisin kombinasyon tedavileri

TALAN L., ALTINTAŞ N. D., Yılmaz G., Guven G., YÖRÜK F.
Gazi Medical Journal , vol.32, no.4, pp.532-535, 2021 (ESCI, Scopus)

24. Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units

GÜNDOĞAN K., AKBUDAK İ. H., Hanci P., HALAÇLI B., TEMEL Ş., Gullu Z., et al.
BALKAN MEDICAL JOURNAL , vol.38, no.5, pp.296-305, 2021 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

25. Does Age Have an Effect on Outcome in Critically Ill Patients with Acute Kidney Injury?

TALAN L., ALTINTAŞ N. D.
Ankara Üniversitesi Tıp Fakültesi Mecmuası , vol.71, no.74, pp.77-81, 2021 (TRDizin)

26. Factors Affecting Mortality in Hematology Patients Accepted to the Intensive Care Unit

Talan L., Altıntaş N. D.
ERCIYES MEDICAL JOURNAL , vol.43, no.2, pp.152-155, 2021 (ESCI, TRDizin) Creative Commons License Sustainable Development

27. Response to SARS-CoV-2 associated Guillain-Barre syndrome after awaking on the ICU: Consider differentials

KOCA A., TALAN L., ŞAHİN T., ÇINAR G., EVREN E., KARAHAN Z. C., et al.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.3, pp.431-432, 2021 (ESCI, Scopus, TRDizin) Sustainable Development

28. An unusual course of SARS-CoV-2 infection: Challenging diagnosis of Guillain-Barre Syndrome

KOCA A., TALAN L., ŞAHİN T., ÇINAR G., EVREN E., KARAHAN Z. C., et al.
TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , vol.69, no.2, pp.242-246, 2021 (ESCI, Scopus, TRDizin) Sustainable Development

29. COVID-19 pneumonia and pneumothorax: case series

Talan L., Şaşal Solmaz F. G., Ercan U., Akdemir Kalkan İ., Kayı Cangır A., Yüksel C., et al.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.68, no.4, pp.437-443, 2020 (ESCI, Scopus, TRDizin) Sustainable Development

30. Successful treatment of COVID-19 infection in a patient with tracheostomy

ÖZ M., GÜRÜN KAYA A., VELİOĞLU YAKUT Ö., GÜLTEN E., TALAN L., EROL S., et al.
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.68, no.4, pp.444-448, 2020 (ESCI, Scopus, TRDizin) Sustainable Development

31. COVID-19 and Intensive Care

TALAN L., ALTINTAŞ N. D.
ASTIM ALLERJI IMMUNOLOJI , vol.18, pp.15-18, 2020 (ESCI, TRDizin) Creative Commons License Sustainable Development

32. Low Cortisol Levels as a Cause of Hypotension During Extended ICU Stay

TALAN L., Guven G., ALTINTAŞ N. D.
JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , vol.10, no.2, pp.41-46, 2019 (ESCI, TRDizin)

33. Current Statement of Intensive Care Units in Turkey: Data obtained from 67 Centers

Ediboglu O., Mocin O. Y., ÖZYILMAZ E., Salturk C., Onalan T., SEYDAOĞLU G., et al.
TURKISH THORACIC JOURNAL , vol.19, no.4, pp.209-215, 2018 (ESCI, Scopus) Creative Commons License

34. Hemophagocytic lymphohistiocytosis after certolizumab treatment in a patient with rheumatoid arthritis

Guven G., Guler A., ÖZYÜNCÜ N., TALAN L., HEPER A., TURGAY T. M., et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY , vol.5, no.3, pp.203-205, 2018 (ESCI, TRDizin) Sustainable Development

35. Hasta ventilatör ilişkisi. Güncel Göğüs Hastalıkları Serisi ‘Mekanik Ventilasyonda Son Gelişmeler’ sayısında

TALAN L., ALTINTAŞ N. D.
Güncel Göğüs Hastalıkları Serisi , pp.23-30, 2018 (Non Peer-Reviewed Journal)

36. Non-Pseudomonal Ecthyma Gangrenosum

TALAN L., Okyar A., YÖRÜK F., ALTINTAŞ N. D.
GAZI MEDICAL JOURNAL , vol.29, no.4, pp.357-358, 2018 (ESCI, Scopus, TRDizin)

37. Bakımda Organ Yetmezliklerinde ve Özel Hasta Gruplarında Nütrisyon Uygulamaları

TALAN L., ALTINTAŞ N. D.
Türkiye Klinikleri Yoğun Bakım Özel Dergisi , 2017 (Non Peer-Reviewed Journal)

38. An Unexpected Fatal CCHF Case and Management of Exposed Health Care Workers

Guven G., TALAN L., ALTINTAŞ N. D., MEMİKOĞLU K. O., YÖRÜK F., AZAP A.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES , vol.55, pp.118-121, 2017 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

39. Microorganisms that are Difficult to Control in the Intensive Care Units: Acinetobacter

TALAN L., Guven G., Yilmaz G., ALTINTAŞ N. D.
JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , vol.6, no.2, pp.44-47, 2015 (ESCI, Scopus, TRDizin)

40. Dysphagia-A Common, Transient Symptom in Critical Illness Polyneuropathy: A Fiberoptic Endoscopic Evaluation of Swallowing Study

TALAN L.
JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , vol.6, no.1, pp.17-18, 2015 (ESCI, Scopus, TRDizin)

41. Effects of plasma Cortisol Levels and Corticosteroid Therapy on Mortality in Septic Shock Patients

TALAN L., AYGENCEL BIKMAZ Ş. G., Cakir N., Turkoglu M. A.
GAZI MEDICAL JOURNAL , vol.26, no.4, pp.139-142, 2015 (ESCI, Scopus, TRDizin)
Metrics

Publication

82

Publication (WoS)

37

Publication (Scopus)

31

Citation (WoS)

116

H-Index (WoS)

6

Citation (Scopus)

365

H-Index (Scopus)

8

Citation (Scholar)

465

H-Index (Scholar)

9

Citation (TrDizin)

7

H-Index (TrDizin)

2

Citation (Sobiad)

30

H-Index (Sobiad)

3

Citation (Sum Other)

7

Project

3

Thesis Advisory

2

Open Access

9
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING